This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Maxygen" – news · newspapers · books · scholar · JSTOR(March 2008) (Learn how and when to remove this message)
Maxygen
Company type
Public
Traded as
Nasdaq: MAXY
Industry
industrial biotechnology, pharmaceuticals
Founded
1997
Defunct
2013; 11 years ago (2013)
Headquarters
Redwood City, CA
Key people
Russell J. Howard (CEO) Alejandro Zaffaroni Willem P.C. Stemmer Isaac Stein
Website
www.maxygen.com
Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification technologies.[1] The company was headquartered in Redwood City, CA. It dissolved in 2013. The Maxygen legacy was revived in 2018 with a focus on Directed Evolution of Proteins using Molecular Breeding. Maxygen LLC is currently headquartered in Sunnyvale, CA.
^"The Birth of Supergenes". The Manhattan Mercury. Manhattan, Kansas. New York Times News Service. 29 November 1998. pp. C6. Retrieved 4 November 2022 – via Newspapers.com.
Maxygen Inc. was a biopharmaceutical company focused on developing improved versions of protein drugs using DNA shuffling and other protein modification...
acquired by Maxygen in 2000, for $60 million in stock. From its acquisition by Maxygen until 2008, the company continued as a subsidiary of Maxygen forming...
2002. It went public in April 2010 on NASDAQ, and in October, acquired Maxygen's MolecularBreeding technology portfolio. Codexis won the Presidential Green...
combinatorial chemistry technologies. Other companies he founded include Maxygen (1997), a developer of technologies that improve the development of proteins...
Silicon Valley high technology companies, including Flextronics, Magma, Maxygen, Monogram Biosciences, Silicon Spice, Symyx, and Syrrx. While at Presidio...
Møller Mikkelsen, and remained co-CEO thereof until its acquisition by Maxygen in 2000. In 2001, he co-founded the investment firm Nordic Biotech Advisors...
for founding Alza Pharmaceuticals, Affymetrix, Symyx Technologies and Maxygen; in Montevideo (d. 2014) Thérèse Vanier, English physician, humanitarian...
Global Information
